¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"RE"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
  • JrId: 6916
    JournalTitle: Research quarterly.
    MedAbbr: Res Q
    ISSN: 0034-5377
    ESSN:
    IsoAbbr:
    NlmId: 401301
  • JrId: 6917
    JournalTitle: Research quarterly for exercise and sport.
    MedAbbr: Res Q Exerc Sport
    ISSN: 0270-1367
    ESSN:
    IsoAbbr:
    NlmId: 8006373
  • JrId: 6918
    JournalTitle: Research in reproduction.
    MedAbbr: Res Reprod
    ISSN: 0034-5253
    ESSN:
    IsoAbbr:
    NlmId: 210606
  • JrId: 6919
    JournalTitle: Research and statistics note - Health Care Financing Administration, Office of Policy, Planning, and Research.
    MedAbbr: Res Stat Note Health Care Financ Adm Off Policy Plan Res
    ISSN: 0196-1241
    ESSN:
    IsoAbbr:
    NlmId: 7903582
  • JrId: 6920
    JournalTitle: Research in veterinary science.
    MedAbbr: Res Vet Sci
    ISSN: 0034-5288
    ESSN:
    IsoAbbr: Res. Vet. Sci.
    NlmId: 401300
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • X14.1
    Residential institution
    Áý´Ü°ÅÁֽü³
  • W07.1
    Residential institution
    Áý´Ü°ÅÁֽü³
  • Y10.1
    Residential institution
    Áý´Ü°ÅÁֽü³
  • X86.1
    Residential institution
    Áý´Ü°ÅÁֽü³
  • W86.1
    Residential institution
    Áý´Ü°ÅÁֽü³
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • recurrent interosseous artery
    »À»çÀ̵ǵ¹À̵¿¸Æ, ¹Ýȸ°ñ°£µ¿¸Æ
  • recurrent laryngeal nerve
    µÇµ¹ÀÌÈĵνŰæ, ¹ÝȸÈĵνŰæ
  • recurrent ophthalmoplegia
    ¹Ýº¹´«±ÙÀ°¸¶ºñ
  • recurrent projection
    ȸ±ÍÅõ»ç
  • recurrent reaction
    Àç¹ß¹ÝÀÀ
  • recurrent sensibility
    ȸ±Í°¨°¢
  • recurrent stricture
    Àç¹ßÇùÂø
  • recurrent subluxation
    Àç¹ß¾ÆÅ»±¸
  • recurvation
    Èı¼
  • red
    1. ºÓÀº 2. Àû»ö- 3. Àû»ö 4. ·¹µå
  • red anomaly
    Àû»ö¾à, Àû»ö°¢ÀÌ»ó
  • red blood cell
    ÀûÇ÷±¸
  • red blood cell dysmorphism
    ÀûÇ÷±¸ÇüÅÂÀÌ»ó(Áõ)
  • red blood corpuscle
    ÀûÇ÷±¸
  • red cell aplasia
    ÀûÇ÷±¸¹«Çü¼º
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • replacement
    ´ëÄ¡(¼ú), ±³È¯, ġȯ
  • replacement therapy
    ´ëÄ¡¿ä¹ý
  • replantation
    ÀçÁ¢ÇÕ(¼ú)
  • replenisher
    º¸Ãæ¹°
  • replication
    º¹Á¦
  • replicon
    º¹Á¦´ÜÀ§
  • repolarization
    ÀçºÐ±Ø
  • repopulation
    ÀçÁõ½Ä
  • report
    º¸°í
  • reposition
    Àç¹èÄ¡, À§Ä¡º¹¿ø
  • repositioning
    Àç¹èÄ¡, À§Ä¡º¹¿ø
  • repositor
    Á¤À§Ä¡±â
  • repression
    ¾ï¾Ð
  • reproducibility
    ÀçÇö¼º
  • reproduction
    »ý½Ä
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • rectovesical septum
    °ðâÀڹ汤»çÀ̸·, Á÷À广±¤»çÀ̸·
  • rectovestibular fistula
    °ðâÀÚÁú¾î±Í»û±æ
  • rectum
    °ðâÀÚ, Á÷Àå
  • rectus
    °ðÀº-, Á÷
  • rectus abdominis muscle
    ¹è°ðÀº±Ù, º¹Á÷±Ù
  • rectus abdominis muscle flap
    ¹è°ðÀº±ÙÆÇ, º¹Á÷±ÙÆÇ
  • rectus capitis muscle
    ¸Ó¸®°ðÀº±Ù
  • rectus femoris muscle
    ³Ò´Ù¸®°ðÀº±Ù, ´ëÅðÁ÷±Ù
  • rectus femoris muscle flap
    ³Ò´Ù¸®°ðÀº±ÙÆÇ, ´ëÅðÁ÷±ÙÆÇ
  • rectus muscle
    °ðÀº±Ù
  • rectus sheath
    ¹è°ðÀº±ÙÁý
  • recumbent
    ´©À½-
  • recumbent position
    ¸ð·Î´©¿îÀÚ¼¼, Ⱦ¿ÍÀ§
  • recurrence
    Àç¹ß
  • recurrence risk
    Àç¹ßÀ§Çèµµ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • rectal atresia ³ª
    Á÷ÀåÆó¼â(¡­øÍáð)
  • rectal bleeding =archorragia
    Á÷ÀåÃâÇ÷(Á÷ÀåÃâÇ÷).
  • rectal bleeding =archorragia
    Á÷ÀåÃâÇ÷(¡­õóúì)
  • rectal bleeding, radiation induced
    ¹æ»ç¼±À¯¹ß Á÷ÀåÃâÇ÷
  • rectal capillary pressure
    Á÷Àå¸ð¼¼°ü¾Ð(Á÷Àå¸ð¼¼°ü¾Ð).
  • rectal column
    Á÷Àå±âµÕ, Á÷ÀåÁÖ(òÁ ñº).
  • rectal column
    Á÷Àå±âµÕ, Á÷ÀåÁÖ(òÁíóñº).
  • rectal constipation
    Á÷À强 º¯ºñ(¡­àõøµù²).
  • rectal constipation
    Á÷À强 º¯ºñ(¡­àõøµù²)
  • rectal crisis
    Á÷Àå¹ßÁõ(òÁíóÛ¡ñø).
  • rectal crisis
    Á÷Àå¹ßÁõ(¡­Û¡ñø)
  • rectal dyschezia
    Á÷À强 ¹èº¯°ï¶õ(¡­¼º¹èÆí°ï³­).
  • rectal dyschezia
    Á÷À强 ¹èº¯°ï¶õ(¡­àõÛÉøµÍÝÑñ)
  • rectal fistula
    °ðâÀÚ´©Ãâ°ü
  • rectal fistula
    Á÷Àå·ç(¡­íóת)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • reciprocal beat
    »ó¹Ý¸Æ¹Ú.
  • reciprocal conduction
    »ó¹ÝÀüµµ.
  • reciprocal crossing
    »ó¹Ý±³¹è(ßÓÚãÎßÛÕ), ¿ª±³Àâ(æ½ÎßíÚ).
  • reciprocal difference
    ¿ªÂ÷ºÐ(æ½ó¬ÝÂ).
  • reciprocal hybrid
    »ó¹ÝÀâÁ¾(ßÓÚãíÚðú).
  • reciprocal inhibition
    »óÈ£¾ïÁ¦
  • reciprocal inhibition
    »ó¹Ý¾ïÁ¦(ßÓÚãåäð¤).
  • reciprocal inhibition psychotherapy
    »óÈ£Á¦ÁöÁ¤½ÅÄ¡·á.
  • reciprocal innervation
    »ó¹ÝÀû½Å°æÁö¹è
  • reciprocal innervation
    »ó¹Ý½Å°æÁö¹è(ßÓÚããêÌèò¨ÛÕ).
  • reciprocal proportion
    ¹Ýºñ·Ê(ËÑËÓËç).
  • reciprocal retention
    »ó¹ÝÁ¤Ã¼(ßÓÚãïÎôò).
  • reciprocal rhythm
    Àç±Í¸®µë
  • reciprocal shaker
    ¿Õº¹ÁøÅÁ±â
  • reciprocal shaker
    ¿Õº¹ÁøÅÁ±â(èÙÜÖòè.JÐï).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • resorcinol test
    ¸®Á¶¸£½Ã³î ½ÃÇè(ãËúÐ)
  • respiratory acidosis
    È£Èí»êÁõ(û¼ýåß«ñø)
  • respiratory alkalosis
    È£Èì¾ËÄ®¸®Áõ(ñø)
  • respiratory assembly
    È£Èí ¾Æ
  • respiratory burst
    È£Èí ±ÞÁõ(Ðáñø)
  • respiratory chain
    È£Èí ¿¬¼â(Ö§áð)
  • respiratory chain phosphorylation
    È£Èí¿¬¼â ÀλêÈ­(×òß«ûù)
  • respiratory complex
    È£Èí º¹ÇÕü(ÜÜùêô÷)
  • respiratory control
    È£Èí Á¶Àý(ðàï½)
  • respiratory enzyme
    È£Èí È¿¼Ò(ý£áÈ)
  • respiratory enzyme complex
    È£Èí È¿¼Ò º¹ÇÕü(ÜÜùêô÷)
  • respiratory inhibitor
    È£Èí ÀúÇØÁ¦(îÁúªð¥)
  • respiratory pigment
    È£Èí »ö¼Ò(ßäáÈ)
  • respiratory poison
    È£Èí µ¶¼Ò(Ô¸áÈ)
  • respiratory protein
    È£Èí ´Ü¹éÁú(Ó±ÛÜòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • reticuloendothelial
    (¼¼)¸Á³»(ÇÇ)ÀÇ
  • reticuloendothelial system
    ¼¼¸Á³»Çǰè, ¸Á³»°è
  • reticuloendothelioma
    ¼¼¸Á³»ÇÇÁ¾
  • reticuloendotheliosis
    ¼¼¸ÁÁ¶Á÷Áõ½ÄÁõ, ¼¼¸Á³»ÇÇÁõ
  • reticulohistiocytoma
    ¼¼¸ÁÁ¶Á÷±¸Á¾
  • reticulohistiocytosis
    ¼¼¸ÁÁ¶Á÷±¸Áõ½ÄÁõ
  • reticulosis
    ¼¼¸ÁÁõ
  • reticulum
    ¼¼¸Á, ¸Á»óü
  • reticulum cell
    ¼¼¸Á¼¼Æ÷
  • reticulum cell sarcoma
    ¼¼¸Á¼¼Æ÷À°Á¾
  • retina
    ¸Á¸·
  • retinal
    ¸Á¸·ÀÇ
  • retinal bleeding
    ¸Á¸·ÃâÇ÷
  • retinal detachment
    ¸Á¸·¹Ú¸®
  • retinal vein
    ¸Á¸·Á¤¸Æ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • reinduction
    ÀçÀ¯µµ
  • reinfection
    Àç°¨¿°
    °°Àº º´¿øÃ¼¿¡ ´ëÇÑ µÎ ¹øÂ° °¨¿° ¶Ç´Â ½ÅÀå°ú °°ÀÌ ´Ù¸¥ º´¿øÃ¼¿¡ ÀÇÇÑ ±â°üÀÇ µÎ ¹øÂ° °¨¿°.
  • reinforced anchorage
    °¡°­ °íÁ¤
    µ¿ÀǾî=multi
  • reinforced ZOE cement
    °­È­ »êÈ­ ¾Æ¿¬ À¯Áö³î ½Ã¸àÆ®
  • reinforcement line
    °­È­¼±
  • reinforcement with operant conditions
    µµ±¸Àû Á¶°ÇÀ» »ç¿ëÇÑ °­È­¹ý
  • reinforcing material
    º¸°­Á¦
    °­È­³ª Áõ°­À» ÀÏÀ¸Å°´Â ¹°Áú.
  • Reiter syndrome
    ¶óÀÌÅÍ ÁõÈıº
    óÀ½¿¡ ¼³»ç¸¦ Çϰí, À̾ ¿äµµ¿°, °á¸·¿° ¹× À¯ÁÖ¼ºÀÇ ´Ù¹ß¼º °üÀý¿°À» ÁÖ Áõ¼¼·Î ÇÏ´Â ¿øÀÎ ºÒ¸íÀÇ º´. ÇǺÎÀÇ º´º¯À̳ª ±× ¹ÛÀÇ Áõ¼¼°¡ ¼ö¹ÝµÇ´Â ÀÏÀÌ ¸¹´Ù. °ÅÀÇ ÀþÀº ³²¼º¿¡°Ô¸¸ ³ªÅ¸³ª°í, ¿©¼º¿¡°Ô´Â ¸Å¿ì µå¹°´Ù. ´ëºÎºÐ ¼ö°³¿ù ³»¿¡ ÀúÀý·Î ³ªÀ¸¸ç ÈÄÀ¯ÁõÀº ¾øÀ¸³ª Àç¹ßÇϱ⠽±´Ù. 1916³â µ¶ÀÏÀÇ ÀÇ»ç H. ¶óÀÌÅͰ¡ ±âÀç, º¸°íÇÏ¿´´Ù.
  • Reiter's syndrome
    ¶óÀÌÅÍ ÁõÈıº
    1. ´Ù¼Ò À¶±âµÈ Àû»ö ¹ÝÁ¡ÀÌ ¹é»ö º¯¿¬À¸·Î ºÒ±ÔÄ¢ÇÏ°Ô Á¦ÇÑµÈ »óÅ·Π°üÂûµÉ ¼ö ÀÖ°í. ¶§¶§·Î ÃâÇ÷¼º ¹ÝÁ¡À» ³ªÅ¸³¾ ¼öµµ ÀÖ´Ù. Çô¿¡¼­´Â ÀÌȯµÇÁö ¾Ê´Â ÁÖº¯ ºÎÀ§¿Í ±¸º°µÇ´Â ¹àÀº »öÀÇ °æ°èºÎ¸¦ °¡Áö´Â ¹ÝÁ¡ º´¼Ò°¡ ¹ß°ßµÈ´Ù. 2. º¸Åë ºñƯÀ̼º ºñÀÓ±Õ¼º ¿äµµ¿°¿¡ µÚµû¶ó ³ªÅ¸³ª´Â °üÀý¿°, ¿äµµ¿°, °á¸·¿°ÀÇ 3ÁÖ¡ÀÌ ÀÖÀ¸¸ç ³²¼º¿¡¼­ È£¹ßÇÑ´Ù. ±¸³»¿°°ú À½°æ ±ÍµÎÀÇ ±Ë¾çÀÌ °ü·ÃµÉ ¼ö ÀÖ´Ù.
  • rejection
    °ÅÀý, °ÅºÎ, ±â°¢, °ÅºÎ ¹ÝÀÀ
    ÀÌ½Ä Á¶Á÷¿¡ ´ëÇÑ ¸é¿ª ¹ÝÀÀ. °úÀ× ¿¹¹Î¼º °ÅºÎ·Î ±âÁ¸ÀÇ Ç×ü¿¡ ÀÇÇÏ¿© ÀÌ½ÄÆí¿¡ ´ëÇÑ Áï½Ã ÀÀ´ä ¹ÝÀÀÀÌ ÀϾ ¼¶À¯¼Ò Ä§Âø, Ç÷¼ÒÆÇ ÀÀÁý, È£Áß±¸ ħÀ±ÀÌ ÀϾ¸ç °á±¹Àº À̽ÄÀÇ ½ÇÆÐ·Î ³¡³­´Ù.
  • rejoining
    ÀçÀ¶ÇÕ
  • relapse caries
    Àç¹ß ¿ì½Ä
  • relapsing fever
    Àç±Í¿­
    Àç±Í¿­ ½ºÇÇ·ÎÇìŸ ¶Ç´Â Æ®·¹Æ÷³×¸¶¿¡ ÀÇÇÏ¿© ÀϾ´Â ±Þ¼º Àü¿°º´. ȸ±Í¿­À̶ó°íµµ ÇÑ´Ù. ¼¼°è °¢Áö ƯÈ÷ ¿­´ë±Ç¿¡ ¸¹ÀÌ ºÐÆ÷Çϴ dzÅ亴ÀÇ ÇϳªÀÌ´Ù. º´¿øÃ¼´Â Àç±Í¿­ ½ºÇÇ·ÎÇìŸÀ̸ç, ȯÀÚ ¶Ç´Â º´¿øÃ¼¸¦ º¸À¯ÇÏ´Â Á㳪 ´Ù¶÷Áã µîÀÇ ÀÛÀº µ¿¹°·ÎºÎÅÍ ÀÌ, º­·è, Áøµå±âÀÇ ¸Å°³¿¡ ÀÇÇÏ¿© °¨¿°µÈ´Ù. Àẹ±â´Â 3¡­9ÀÏÀ̰í, °©Àڱ⠿ÀÇÑÀÌ ³ª¸é¼­ 40 ¡É ÀüÈÄ·Î ¹ß¿­ÇÑ´Ù. µÎÅë, ¿äÅë, ±ÙÀ°Åë ¿Ü¿¡ ½Ä¿å ºÎÁø, ±¸Åä, Ȳ´Þ µîÀÌ ³ªÅ¸³ª°í, ÁßÁõÀÏ ¶§´Â ÀǽÄÀÌ È¥Å¹ÇØÁö¸ç ÇÇÇÏ ÃâÇ÷ µîµµ º¸ÀδÙ. ¿­Àº 4~10Àϰ£ °è¼ÓµÈ ÈÄ ÀÏ´Ü ¼ö±×·¯Áö°í ±× ¹ÛÀÇ Áõ¼¼µµ °¡º­¿öÁöÁö¸¸, ¾à lÁÖ°£ÀÇ Æò¿­ ±â°£À» µÎ°í Àç¹ß¿­ÇÏ¿© °°Àº Áõ¼¼¸¦ ¹Ýº¹ÇÏ´Â °ÍÀÌ Æ¯Â¡À̸ç, ¸í¸íÀÇ À¯·¡µµ ¿©±â¿¡ ÀÖ´Ù. ¶§·Î´Â 3~4ȸ³ª ¹Ýº¹ÇÏ´Â ¼öµµ ÀÖÀ¸³ª, Ƚ¼öÀÇ Áõ°¡¿¡ µû¶ó¼­ ¿­ÀÇ ³ôÀÌ´Â ³·¾ÆÁö°í À¯¿­ ±â°£µµ ´ÜÃàµÇ´Â ÇÑÆí, Æò¿­ ±â°£ÀÌ ±æ¾îÁø´Ù. Æä´Ï½Ç¸° µîÀÇ Ç×»ý ¹°ÁúÀ̳ª ºñ¼ÒÁ¦°¡ À¯È¿Çϸç, ÀÌ Áúº´À¸·Î »ç¸ÁÇÏ´Â ÀÏÀº °ÅÀÇ ¾ø´Ù.
  • related
    ±ÙÄ£ÀÇ
  • related heteroantigen
    ÀÌÁ¾ Ç׿ø
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
receptors, tumour necrosis factor Cell surface receptors that bind tumour necrosis factor and trigger changes which influence the behaviour of cells. The two recognised tumour necrosis factor receptors are designated alpha and beta receptors. Both receptors bind both alpha and beta tumour necrosis factors with high affinity, and both are members of the nerve growth factor receptor family.
(12 Dec 1998)
receptors, vasoactive intestinal peptide Cell surface proteins that bind vasoactive intestinal peptide (vip) with high affinity and trigger intracellular changes which influence the behaviour of cells.
(12 Dec 1998)
receptors, vasopressin Specific molecular sites or structures on or in cells that vasopressins react or to which they bind in order to modify the function of the cells. Two types of vasopressin receptor exist, the v1 receptor and the v2 receptor. The v1 receptor can be subdivided into v1a and v1b (formerly v3) receptors.
(12 Dec 1998)
receptors, very late antigen Members of the integrin family appearing late after T-cell activation. They are a family of proteins initially identified at the surface of stimulated T-cells, but now identified on a variety of cell types. At least six vla antigens have been identified as heterodimeric adhesion receptors consisting of a single common beta-subunit and different alpha-subunits.
(12 Dec 1998)
receptors, virus Specific molecular components of the cell capable of recognizing and interacting with a virus, and which, after binding it, are capable of generating some signal that initiates the chain of events leading to the biological response.
(12 Dec 1998)
receptors, vitronectin Alpha-v beta-3 integrins that bind vitronectin with high affinity and play a role in cell migration. They also bind fibrinogen, von willebrand factor, osteopontin, and thrombospondin. The highly homologous alpha-v beta-5 integrin also binds vitronectin, but mediates simple adhesion.
(12 Dec 1998)
receptosomes Vesicles that avoid lysosomes and deliver their contents to other intracellular sites.
(05 Mar 2000)
recess 1. A withdrawing or retiring; a moving back; retreat; as, the recess of the tides. "Every degree of ignorance being so far a recess and degradation from rationality." (South) "My recess hath given them confidence that I may be conquered." (Eikon Basilike)
2. The state of being withdrawn; seclusion; privacy. "In the recess of the jury they are to consider the evidence." (Sir M. Hale) "Good verse recess and solitude requires." (Dryden)
3. Remission or suspension of business or procedure; intermission, as of a legislative body, court, or school. "The recess of . . . Parliament lasted six weeks." (Macaulay)
4. Part of a room formed by the receding of the wall, as an alcove, niche, etc. "A bed which stood in a deep recess." (W. Irving)
5. A place of retirement, retreat, secrecy, or seclusion. "Departure from his happy place, our sweet Recess, and only consolation left." (Milton)
6. Secret or abstruse part; as, the difficulties and recesses of science.
7. <botany> A sinus.
Origin: L. Recessus, fr. Recedere, recessum. See Recede.
Source: Websters Dictionary
(01 Mar 1998)
recession A withdrawal or retreating.
See: retraction.
Origin: L. Recessio (see recessus)
(05 Mar 2000)
recessitivity The state of being recessive.
(05 Mar 2000)
recessive <genetics> An allele or mutation that is only expressed phenotypically when it is present in the homozygous form. In the heterozygote it is obscured by dominant alleles.
(18 Nov 1997)
recessive character An inherited character determined by an allele in homozygous state only.
See: dominance of traits.
(05 Mar 2000)
recessive gene A gene that is expressed onlywhen it is present in two copies or if theother copy is missing.
(09 Oct 1997)
recessive inheritance dominance of traits
recessive oncogene <molecular biology> A single copy of this gene issufficient to suppress cell proliferation, the loss of both copies of the gene contributes to cancer formation.
(09 Oct 1997)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 20
  • Receptor-CD3 Complex, Antigen, T-Cell - »õâ Molecule composed of the non-covalent association of the T-cell antigen receptor (RECEPTORS, ANTIGEN, T-CELL) with the CD3 complex (ANTIGENS, CD3). This association is required for the surface expression and function of both components. The molecule consists of up to seven chains: either the alpha/beta or gamma/delta chains of the T-cell receptor, and four or five chains in the CD3 complex.
    Synonyms : Complex, TCR-CD3, T Cell Antigen Receptor CD3 Complex, TCR CD3 Complex
  • Receptor-Interacting Protein Serine-Threonine Kinase 2 - »õâ A RIP serine-theonine kinase that contains a C-terminal caspase activation and recruitment domain. It can signal by associating with other CARD-signaling adaptor proteins and INITIATOR CASPASES that contain CARD domains within their N-terminal pro-domain region.
    Synonyms : CARD-containing Interleukin (IL)-1 beta Converting Enzyme, CARDIAK, RICK Protein, RIPK2 Protein, Receptor-Interacting Serine-Threonine Kinase 2, Receptor Interacting Protein Serine Threonine Kinase 2, Receptor Interacting Serine Threonine Kinase 2
  • Receptor-Interacting Protein Serine-Threonine Kinases - »õâ A family of serine-threonine kinases that plays a role in intracellular signal transduction by interacting with a variety of signaling adaptor proteins such as CRADD SIGNALING ADAPTOR PROTEIN; TNF RECEPTOR-ASSOCIATED FACTOR 2; and TNF RECEPTOR-ASSOCIATED DEATH DOMAIN PROTEIN. Although they were initially described as death domain-binding adaptor proteins, members of this family may contain other protein-binding domains such as those involving caspase activation and recruitment.
    Synonyms : RIP Serine-Threonine Kinase, RIP(Receptor Interacting Protein), Receptor Interacting Protein RIP, Receptor-Interacting Protein Serine-Threonine Kinase 1, Receptor-Interacting Protein Serine-Threonine Kinase 3, Kinase, RIP Serine-Threonine
  • Receptors, Adenosine A2 - »õâ A subclass of ADENOSINE RECEPTORS that are generally considered to be coupled to the GS, STIMULATORY G-PROTEIN which causes up regulation of CYCLIC AMP.
    Synonyms : Adenosine A2 Receptor, A2 Receptor, Adenosine, A2 Receptors, Adenosine, Receptor, Adenosine A2
  • Receptors, Adrenergic - »õâ Cell-surface proteins that bind epinephrine and/or norepinephrine with high affinity and trigger intracellular changes. The two major classes of adrenergic receptors, alpha and beta, were originally discriminated based on their cellular actions but now are distinguished by their relative affinity for characteristic synthetic ligands. Adrenergic receptors may also be classified according to the subtypes of G-proteins with which they bind; this scheme does not respect the alpha-beta distinction.
    Synonyms : Adrenergic Receptor, Epinephrine Receptors, Norepinephrine Receptors, Receptor, Adrenergic
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 10 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
·¹¹Ù½ÅÁ¤ - »õâ
µ¿½ÅÁ¦¾à
A15107201 Rebamipide
Àü¹®ÀǾàǰ | »èÁ¦
·¹¹Ù½ÃµåÁ¤ - »õâ
¸ÞµðÄ«ÄÚ¸®¾Æ
A10003651 Rebamipide
Àü¹®ÀǾàǰ | ±Þ¿©
ÆÄ¸¶Å··¹¹Ù¸ÞµåÁ¤ - »õâ
ÆÄ¸¶Å·
A17001091 Rebamipide
Àü¹®ÀǾàǰ | ±Þ¿©
·¹¹ÙµàÁ¤ - »õâ
SKÄɹÌÄ®
A18901911 Rebamipide
Àü¹®ÀǾàǰ | »èÁ¦
º¸·É·¹¹Ù¹ÌÇǵåÁ¤100mg - »õâ
º¸·ÉÁ¦¾à
A09305571 Rebamipide
Àü¹®ÀǾàǰ | ±Þ¿©
ºñ¾ÆµåÁ¤ - »õâ
»ïõ´çÁ¦¾à
A08403511 Rebamipide
Àü¹®ÀǾàǰ | ±Þ¿©
¸®¹Ù¹ÌµåÁ¤ - »õâ
¾Ë¾ØÇÇÄÚ¸®¾Æ
A43900341 Rebamipide
Àü¹®ÀǾàǰ | ±Þ¿©
ÀϾ緹¹Ù¹ÌÇǵåÁ¤100mg - »õâ
ÀϾç¾àǰ
A09505591 Rebamipide
Àü¹®ÀǾàǰ | ±Þ¿©
Ææ¹ÌµåÁ¤ - »õâ
°ÇÀÏÁ¦¾à
A80100031 Rebamipide
Àü¹®ÀǾàǰ | ±Þ¿©
¹Ù¹ÌµåÁ¤ - »õâ
Çѱ¹ÇÁ¶óÀÓÁ¦¾à
A62700461 Rebamipide
Àü¹®ÀǾàǰ | ±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 10 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
reproduction the process of generating offspring recall that is hypothesized to work by storing the original stimulus input and reproducing it during recall replica: copy that is not the original; something that has been copied the act of making copies; "Gutenberg's reproduction of holy texts was far more efficient" the sexual activity of conceiving and bearing offspring
Ãâó: wordnet.princeton.edu/perl/webwn
reverse transcriptase a polymerase that catalyzes the formation of DNA using RNA as a template; found especially in retroviruses
Ãâó: wordnet.princeton.edu/perl/webwn
retro- ex post facto: affecting things past; "retroactive tax increase"; "an ex-post-facto law"; "retro pay" a fashion reminiscent of the past
Ãâó: wordnet.princeton.edu/perl/webwn
regional characteristic of a region; "regional flora" related or limited to a particular region; "a regional dialect"
Ãâó: wordnet.princeton.edu/perl/webwn
rectum the terminal section of the alimentary canal; from the sigmoid flexure to the anus
Ãâó: wordnet.princeton.edu/perl/webwn
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • rebaptism
    Àç¼¼·Ê;Àç¸í¸í
  • rebaptize
    ´Ù½Ã ¼¼·ÊÇÏ´Ù;´Ù½Ã À̸§À» ºÙÀÌ´Ù
  • rebarbative
    È£°¨À» »çÁö ¸øÇÏ´Â;½ÈÀº;ºÒÄèÇÑ;~ly
  • rebate
    ÇÒÀÎÇÏ´Ù; °¨¼ÒÇÏ´Ù
  • rebate
    ȯºÒ;¸®º£ÀÌÆ®;°¨¼Ò;rebater
  • rebbed
    ´Á°ñÀÌ ÀÖ´Â;À̶ûÀÌ ÀÖ´Â
  • rebec
    3Çö ¾Ç±â
  • rebec(k)
    (Áß¼¼ÀÇ)3Çö ¾Ç±â
  • rebecca
    ¿©ÀÚ À̸§
  • Rebecca
    (¿©ÀÚÀ̸§)(¾ÖĪ Becky);=Rebekah
  • rebeck
    3Çö ¾Ç±â
  • Rebekah
    (¿©ÀÚÀ̸§)¸®ºê°¡(ÀÌ»èÀÇó)
  • rebel
    ¹Ý¿ªÀÚ; ¹ÝÇ×ÇÏ´Â; ¹Ý¿ªÇÏ´Ù
  • rebel
    ¹Ý¿ªÀÚ;¹Ýµµ;¹ÝÇ×ÀÚ;¹Ý¶õ±º º´»ç(³²ºÏÀüÀï ¶§ÀÇ ³²±º º´»ç);³²ºÎ ¹éÀÎ;¹Ý¿ªÀÇ;¸ð¹Ý(¹Ý¿ª)ÇÏ´Ù;¹Ý¶õÀ» ÀÏÀ¸Å°´Ù;(±ÇÀ§.°ü½Àµî¿¡)¹Ý´ëÇÏ´Ù;¹ÝÇ×ÇÏ´Ù;È­ÇÕÇÏÁö ¾Ê´Ù;¹Ý°¨À» °¡Áö´Ù;¹Ý¹ßÇÏ´Ù;¸ö¼­¸®Ä¡´Ù
  • rebeldom
    ¹ÝµµÀÇ Á¦¾ÐÁö¿ª;(³²ºÏ ÀüÀï¶§ÀÇ)³²ºÎ ¿¬¹æ;¹Ýµµ;¹Ý¿ª ÇàÀ§
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 20
RE expand or complete (a thorough-based part in a piece of baroque music) by supplying the harmonies indicated in the figured bass
RE convert into cash
RE earn on some commercial or business transaction
RE successfully completed or brought to an end
RE the attribute of accepting the facts of life and favoring practicality and literal truth
RE the philosophical doctrine that abstract concepts exist independent of their names
RE the philosophical doctrine that physical object continue to exist when not perceived
RE the state of being actual or real
RE an artistic movement in 19th century France
RE a philosopher who believes that universals are real and exist independently of anyone thinking of them
RE a painter who represents the world realistically and not in an idealized or romantic style
RE aware or expressing awareness of things as they really are
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 20
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á